Volunteer challenge with enterotoxigenic Escherichia coli that express intestinal colonization factor fimbriae CS17 and CS19

Journal of Infectious Diseases

Volumn 204, Issue 1, 2011, Pages 60-64

  McKenzie, Robin ^a,b   Porter, Chad K ^c   Cantrell, Joyce A ^c,e   DeNearing, Barbara ^b   O'Dowd, Aisling ^c   Grahek, Shannon L ^b,f   Sincock, Stephanie A ^c,g   Woods, Colleen ^c,h   Sebeny, Peter ^d,i   Sack, David A ^b   Tribble, David R ^d   Bourgeois, A Louis ^b,j   Savarino, Stephen J ^c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^f International Vaccine Institute   (South Korea)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h C W   (United States)

ⁱ US Naval Medical Research Unit No 3 Egypt   (Egypt)

^j PATH Enteric Vaccine Initiative   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIMBRIA PROTEIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AFRICAN AMERICAN; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COLONY FORMING UNIT; DIARRHEA; DOSE RESPONSE; ENTEROTOXIGENIC ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMAN; LOOSE FECES; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SEROCONVERSION; SEROTYPE;

ADHESINS, BACTERIAL; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMAN EXPERIMENTATION; HUMANS; MALE; MIDDLE AGED; VIRULENCE FACTORS; YOUNG ADULT;

EID: 79957931197     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir220     Document Type: Article

References (16)

1. Clements ML, Levine MM, Black RE, et al. Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrob Agents Chemother 1981; 20:104-8. (Pubitemid 11002446)
2. Coster TS, Wolf MK, Hall ER, et al. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infect Immun 2007; 75:252-9. (Pubitemid 46047900)
3. McKenzie R, Bourgeois AL, Frech SA, et al. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine 2007; 25:3684-91. (Pubitemid 46584755)
4. Levine MM, Ristaino P, Marley G, et al. Coli surface antigens 1 and 3 of colonization factor antigen II- positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun 1984; 44:409-20. (Pubitemid 14139007)
5. McConnell M, Hibberd M, Penny M, Scotland S, Cheasty T, Rowe B. Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors. Epidemiol Infect 1991; 106:477-84.
6. Shaheen HI, Khalil SB, Rao MR, et al. Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt. J Clin Microbiol 2004; 42:5588-95. (Pubitemid 39664341)
7. Viboud GI, Jouve MJ, Binsztein N, et al. Prospective cohort study of enterotoxigenic Escherichia coli infections in Argentinean children. J Clin Microbiol 1999; 37:2829-33. (Pubitemid 29391895)
8. Anantha RP, McVeigh AL, Lee LH, et al. Evolutionary and functional relationships of CFA/I and other Class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun 2004; 72:7190-201. (Pubitemid 39552390)
9. Steinsland H, Valentiner-Branth P, Perch M, et al. Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. J Infect Dis 2002; 186:1740-7. (Pubitemid 35463506)
10. McVeigh A, Fasano A, Scott DA, et al. IS1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene. Infect Immun 2000; 68:5710-5.
11. Sjoling A, Wiklund G, Savarino SJ, Cohen DI, Svennerholm AM. Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization Factors. J Clin Microbiol 2007; 45:3295-301. (Pubitemid 47585654)
12. Evans DG, Evans DJ Jr., Tjoa W. Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun 1977; 18:330-7. (Pubitemid 8232204)
13. Svennerholm AM, Holmgren J, Black R, Levine MM, Merson MM. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis 1983; 147:514-22. (Pubitemid 13163192)
14. Ahren C, Wenneras C, Holmgren J, Svennerholm AM. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine 1993; 11:929-34. (Pubitemid 23218800)
15. Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB, Young CR. Immunity to enterotoxigenic Escherichia coli. Infect Immun 1979; 23:729-36. (Pubitemid 9138978)
16. Clemens J, Savarino S, Abu-Elyazeed R, et al. Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method. J Infect Dis 2004; 189:2299-307. (Pubitemid 38757204)